Indeed, immunohistochemical analysis for VE1 mutation was recommended as a predictable methodology for detection of BRAF V600E mutation in alternative tumors like melanoma [29], papillary carcinoma of the thyroid [30, 31], and colorectal carcinoma [32]. Here, BRAF is linked to melanoma.